AN2 Therapeutics, Inc. (Nasdaq: ANTX) is a clinical stage biopharmaceutical company focused on the discovery and development of novel small-molecule therapeutics derived from our boron chemistry platform. Our development pipeline spans hematologic diseases, infectious diseases, and oncology with three Phase 2 studies expected to be active in 2026, two preclinical candidates, as well as advanced research programs focused on targets in oncology, bone disorders, and infectious diseases. We are committed to delivering high-impact drugs to patients that address critical unmet needs and improve health outcomes.
| Website | http://www.an2therapeutics.com |
| Revenue | $71.9 million |
| Employees | 38 (26 on RocketReach) |
| Founded | 2019 |
| Address | 1300 El Camino Real Suite 100, Menlo Park, California 94025, US |
| Technologies |
JavaScript
,
HTML
,
Twitter
+18 more
(view full list)
|
| Industry | Biotechnology, Biotechnology Research, Science and Engineering, Pharmaceuticals, Health Care, Pharmaceutical |
| Keywords | Infectious Disease Treatment, Rare Disease Therapeutics, Drug Development, High Unmet Medical Needs, Biopharmaceutical Research, Pharmaceutical Innovation, Innovative Medicines, Therapeutics Research, Biotechnology Advancements, Clinical Development, Health Solutions, Global Health, New Drug Applications |
| Competitors | Gilead Sciences, ViiV Healthcare, Merck & Co., Inc., Bristol Myers Squibb, AbbVie, Johnson & Johnson, Pfizer, Roche, Regeneron, Amgen +38 more (view full list) |
Looking for a particular AN2 Therapeutics employee's phone or email?
AN2 Therapeutics Questions
The AN2 Therapeutics annual revenue was $71.9 million in 2026.
Eric Easom is the CEO and Co-Founder of AN2 Therapeutics.
26 people are employed at AN2 Therapeutics.
AN2 Therapeutics is based in Menlo Park, California.
Top AN2 Therapeutics Employees
-
Eric Easom
CEO and Co-Founder at AN2 Therapeutics
Menlo Park, CA, US25+ -
Cameron Trenor
Chief Medical Officer at AN2 Therapeutics
Boston, MA, US55+ -
Sanjay Chanda
Chief Development Officer at AN2 Therapeutics
California, United States43 -
Lucy Day
Chief Financial Officer at AN2 Therapeutics
California, United States12 -
Josh Eizen
Chief Legal Officer at AN2 Therapeutics
San Ramon, CA, US45+ -
Alexander Tung
Vice President Quality Assurance at AN2 Therapeutics
California, United States23 -
Sarah Williams
VP, Controller and Principal Accounting Officer at AN2 Therapeutics
California, United States35+ -
Vince Hernandez
Vice President of Chemistry at AN2 Therapeutics
Palo Alto, CA, US25 -
Stephanie Wong
Board Member | Audit Committee Chair at AN2 Therapeutics
South San Francisco, CA, US13 -
25
Related Companies
